Clinical Trials Browser

Phase 3 × Metastatic Castration-sensitive Prostate Cancer × niraparib × Clear all

NCT04497844 2026-04-13

AMPLITUDE

Phase 3 Active not recruiting

696 enrolled 15 charts 3 FDA

Metastatic Castration-sensitive Prostate Cancer